CRMD
Price:
$10.64
Market Cap:
$838.32M
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley ...[Read more]
Industry
Biotechnology
IPO Date
2010-05-13
Stock Exchange
NASDAQ
Ticker
CRMD
According to CorMedix Inc.’s latest financial reports and current stock price. The company's current ROE is 116.00%. This represents a change of 545.53% compared to the average of 17.97% of the last 4 quarters.
The mean historical ROE of CorMedix Inc. over the last ten years is -38.26%. The current 116.00% ROE has changed -403.15% with respect to the historical average. Over the past ten years (40 quarters), CRMD's ROE was at its highest in in the March 2023 quarter at 798.49%. The ROE was at its lowest in in the March 2018 quarter at -1211.52%.
Average
-38.26%
Median
-47.37%
Minimum
-138.33%
Maximum
21.69%
Discovering the peaks and valleys of CorMedix Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 158.69%
Maximum Annual ROE = 21.69%
Minimum Annual Increase = -692.34%
Minimum Annual ROE = -138.33%
| Year | ROE | Change |
|---|---|---|
| 2024 | -21.18% | -67.94% |
| 2023 | -66.06% | 22.47% |
| 2022 | -53.94% | 20.08% |
| 2021 | -44.92% | -9.81% |
| 2020 | -49.81% | -692.34% |
| 2019 | 8.41% | -43.90% |
| 2018 | 14.99% | -30.90% |
| 2017 | 21.69% | -115.68% |
| 2016 | -138.33% | 158.69% |
| 2015 | -53.47% | -90.50% |
The current ROE of CorMedix Inc. (CRMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-47.06%
5-year avg
-47.18%
10-year avg
-38.26%
CorMedix Inc.’s ROE is greater than EyePoint Pharmaceuticals, Inc. (-76.13%), greater than Bicara Therapeutics Inc. Common Stock (-21.67%), greater than Kura Oncology, Inc. (-65.42%), less than ProKidney Corp. (11.01%), greater than Savara Inc. (-69.05%), greater than Arbutus Biopharma Corporation (-50.20%), greater than Palvella Therapeutics, Inc. (-73.14%), greater than Septerna, Inc. (-14.83%), greater than Tango Therapeutics, Inc. (-79.72%), less than Nanobiotix S.A. (155.77%),
| Company | ROE | Market cap |
|---|---|---|
| -76.13% | $1.15B | |
| -21.67% | $1.03B | |
| -65.42% | $1.04B | |
| 11.01% | $723.22M | |
| -69.05% | $1.30B | |
| -50.20% | $847.53M | |
| -73.14% | $1.11B | |
| -14.83% | $1.17B | |
| -79.72% | $1.09B | |
| 155.77% | $1.04B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CorMedix Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CorMedix Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CorMedix Inc.'s ROE?
How is the ROE calculated for CorMedix Inc. (CRMD)?
What is the highest ROE for CorMedix Inc. (CRMD)?
What is the 3-year average ROE for CorMedix Inc. (CRMD)?
What is the 5-year average ROE for CorMedix Inc. (CRMD)?
How does the current ROE for CorMedix Inc. (CRMD) compare to its historical average?